Skip to main content
Journal of Clinical Medicine logoLink to Journal of Clinical Medicine
. 2021 Sep 16;10(18):4179. doi: 10.3390/jcm10184179

Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-Analyses

Rebecca Georgakopoulou 1,, Oraianthi Fiste 1,, Theodoros N Sergentanis 1, Angeliki Andrikopoulou 1, Flora Zagouri 1, Maria Gavriatopoulou 1, Theodora Psaltopoulou 1, Efstathios Kastritis 1, Evangelos Terpos 1,*, Meletios A Dimopoulos 1
Editors: Olga Ciepiela1, Anna Waszczuk-Gajda1, David H Vesole1
PMCID: PMC8469366  PMID: 34575290

Abstract

The precise etiology of multiple myeloma remains elusive, but both genetic and environmental factors have been suggested to contribute to disease risk. Several occupational categories and toxic agents have been implicated as potentially causative, yet findings from the literature are inconsistent. The aim of this review was to summarize and critically comment on the accumulated epidemiological evidence, across published meta-analyses, about the association between occupational exposure and risk of multiple myeloma. Overall, results from eleven meta-epidemiological studies underscore a significantly increased risk for firefighters, hairdressers, and employees exposed to engine exhaust, whereas farming and methylene chloride exposure have been non-significantly correlated with the disease. Further epidemiological studies are of utmost importance whilst emphasis should be placed on occupational hazard surveillance, as such studies will obtain a more accurate picture of disease occurrence in working populations, and will enable both the implementation of preventive actions and the evaluation of their effectiveness.

Keywords: multiple myeloma, occupation, occupational hazards, risk factors, occupational epidemiology

1. Introduction

Multiple myeloma (MM), a proliferative disease of immunoglobulin-secreting mature B cells, known as plasma cells, is the second most frequent hematologic malignancy, accounting for approximately 13% of neoplastic diseases of the blood and 1% of all cancers [1,2,3,4]. In 2018, there were about 160,000 cases of MM, translating to an age-standardized incidence rate of 1.8 per 100,000 persons, while the overall survival has been greatly improved over the past decade with the advances in treatment modalities, with an overall 5-year survival rate of 54% [5,6,7].

Although the precise etiology of the disease has not yet been established, the asymptomatic, premalignant monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) are thought to be precursor states of MM [8,9], whereas male sex, older age, African American ancestry, genetic susceptibility, and obesity have been acknowledged as risk factors [10,11,12,13].

Environmental epidemiology of MM is an increasingly investigated, yet controversial, field. Numerous systematic reviews and meta-analyses for multiple environmental and occupational risk factors associated with MM have been published. Thus far, a systematic review of meta-analyses conducted by Sergentanis T. N. et al. [14] in 2015 examined a wide variety of risk factors for MM, including occupational exposure. As new results from incidence and mortality studies have become available since this systematic review [14], and given the significance of meta-analyses as powerful quantitative tools of occupational health policy [15], we have conducted an updated review of published meta-analyses, in order to provide an overview of the range and validity of the reported associations of diverse occupational risk factors with MM.

2. Materials and Methods

2.1. Search Strategy and Eligibility Criteria

A comprehensive review of published literature was conducted to evaluate associations between occupational risk factors and MM. Eligible studies were systematically sought in MEDLINE/PubMed database up to 31 July 2021. Relevant keywords for the search algorithm were (myeloma OR ‘’multiple myeloma’’) AND (occupation OR ‘’occupational factors’’) AND (meta-analysis OR meta-analyses).

The full text of potentially eligible articles was scrutinized by two authors (RG and OF), who worked independently and blindly to each other. Eligible studies included meta-analyses examining the contribution of the workplace environment to MM. We excluded meta-analyses that investigated occupational risk factors for other medical conditions including other hematological malignancies, meta-analyses that examined non-occupational risk factors for MM, and meta-analyses of therapeutic regimens for MM. Furthermore, reviews, systematic reviews, and pooled analyses were also excluded. We did not apply any language restrictions in the selection of eligible studies.

2.2. Data Extraction

Data extraction and analysis was done independently by two investigators (O.F. and R.G.), and in the case of inconsistencies and/or disagreements the final decision was reached by team consensus. From each eligible meta-analysis, we extracted information on the first author, journal and year of publication, examined risk factors, and number of studies included. We also extracted the number of cases and controls included, the study-specific effect size measure (i.e., risk ratio (RR), odds ratio (OR), hazard ratio (HR)) together with their corresponding confidence interval (CI), the p value (and/or I2) for heterogeneity, and publication bias.

3. Results

From the 37 articles retrieved from our search strategy, nine were deemed irrelevant from their abstracts. From the remaining 28 articles, four were pooled analyses, six were systematic reviews or reviews, one was a retrospective national cohort study, and one evaluated the association between MM incidences and residential exposure to the petrochemical industry. Overall, 11 meta-analyses [16,17,18,19,20,21,22,23,24,25,26] providing results from 165 primary studies of potential occupational risk factors were ultimately eligible for this review, since five [27,28,29,30,31] have been updated by more recent meta-epidemiological studies. Characteristics of the included studies are presented in Table 1.

Table 1.

Characteristics of included meta-analyses.

Author (Publication Year) Risk Factor Number of Primary Studies Total Number of Cases/Total Number of Controls and/or Exposed Cases and/or Unexposed Cases Effect Size Metric Pooled Effect Size (95% CI) I2 (%) p-Value p-Heterogeneity Main Results Publication Bias
Khuder S. A. et al. (1997) [16] Farming 32 studies (19 case–control studies, 5 PMR, 4 SIR, 2 SMR, 2 cohort studies) 4165 exposed cases/NA RR 1.23 (1.14–1.32). The estimator of RR obtained from a meta-analysis restricted to female farmers was 1.23 (1.17–1.29) NA NA NA Positive association between MM and farming No evidence of publication bias
Perrotta C. et al. (2008) [17] Farming (pesticide and herbicide exposure) 28 case–control studies NA OR Farming: OR = 1.39 (1.18–1.65) Significant heterogeneity across the studies NA 0.002 Farmers seem to have increased risk for MM. Exposure to pesticides seems to be a possible risk factor. NA
Pesticide exposure: OR = 1.47 (1.11–1.94) Evidence of heterogeneity across the studies NA 0.09 Evidence of publication bias
Herbicide exposure: OR = 0.97 (0.68–1.38) NA NA NA NA
Donato F. et al. (2020) [18] Glyphosate (herbicide) 3 studies (2 case–control studies, 1 cohort study) 290 exposed cases/NA meta-RR 1.04 (0.67–1.41) 16% NA p = 0.21 No consistent indication of an association between exposure to glyphosate and risk of MM NA
Soteriades E. et al. (2019) [19] Firefighting 8 studies NA Risk estimate for mortality 1.28 (1.03–1.58) NA p < 0.05 NA For MM the authors found statistically significant association with firefighting NA
Takkouche B. et al. (2009) [20] Hairdresser occupation 19 studies (8 case–control studies, 3 PMR, 8 cohort studies) 17,567 cases/68,301 controls (of all hematologic cancers) RR Fixed-effects RR: 1.38 (1.25–1.54). Random-effects RR: 1.62 (1.22–2.14) 0.75 p = 0.0001 NA Substantial MM risk among employees of the hairdressing industry No evidence of publication bias
Sonoda T. et al. (2001) [21] Benzene exposure Benzene and/or organic solvents: 8 case–control studies 15,614 cases/75,054 controls OR 0.74 (0.60–0.90) NA Significantly decreased NA Significant positive association between exposure to engine exhaust and MM. No significant associations between MM and benzene and/or organic solvents, petroleum, and petroleum products. NA
Petroleum: 6 case–control studies 3873 cases/12,250 controls 1.11 (0.96–1.28) Not significant NA
Petroleum products (rubber and/or plastic products): 7 case–control studies 27,925 cases/133,486 controls 1.08 (0.89–1.33) Not significant NA
Engine exhaust: 7 case–control studies 4750 cases/14,580 controls 1.34 (1.14–1.570) Statistically significantly elevated NA
Vlaanderen J. et al. (2011) [22] Benzene exposure 26 cohort studies 284 cases/NA meta-RR 1.12 (0.98–1.27) NA p = 0.35 NA Nonsignificant association between benzene exposure and MM Evidence of publication bias
Onyije F. M. et al. (2021) [23] Benzene exposure 12 studies (5 SIR, 9 SMR studies) NA Risk estimate for incidence and mortality 1.80 (1.28–2.55) for incidence; 1.04 (0.89–1.21) for mortality 0% (for incidence); 16% (for mortality) NA p = 0.81 (for incidence); p = 0.30 (for mortality) Increased risk for both incidence and mortality between petroleum exposure and MM No evidence of publication bias
Karami S. et al. (2015) [24] Trichloroethylene (TCE) exposure 11 studies (9 cohort studies, 2 case–control studies) 114 TCE-exposed cases of MM out of 273,423 subjects (cohort studies). 75 cases and 255 TCE-exposed controls (case–control studies) RR 1.05 (0.88–1.27) 6.69 NA p = 0.76 Meta-analytical results for cohort and case–control studies did not show significant associations between occupational TCE exposure and MM No evidence of publication bias
Liu T. et al. (2013) [25] Methylene chloride exposure 3 studies (1 case–control study, 2 cohort studies) NA OR 2.04 (1.31–3.17) 0% p > 0.1 p = 0.871 Supportive results of a positive significant association of methylene chloride exposure and MM NA
Alicandro G. et al. (2016) [26] Polycyclic aromatic hydrocarbons (PAH) Aluminum production: 5 cohort studies 68/39,241 meta-RR 1.18 (0.93–1.50) 0% NA p = 0.34 Occupational PAH exposure does not associate with a significant excess risk of MM No evidence of publication bias
Iron and steel foundry: 4 cohort studies 23/23,145 1 (0.67–1.51) 0% NA p = 0.26
Asphalt workers: 2 cohort studies 13/30,686 0.72 (0.42–1.23) 0% NA p = 0.77
High exposure level: 0.96 (0.73–1.27) Not significant

Abbreviations: CI = confidence interval; HR = hazard ratio; meta-RR = meta-relative risk; MM = multiple myeloma; NA = not available; OR = odds ratio; PMR = proportionate mortality ratio; RR = relative risk; SIR = standardized incidence ratio; SMR = standardized mortality ratio; SRE = summary risk estimate; SRRE = summary relative risk estimate.

3.1. Agriculture and Farming

Blair A. et al. [27] conducted the first meta-analysis on cancer risk among farmers and found that this occupational group had a significantly elevated risk for MM (OR: 1.12; 95% CI: 1.04–1.21). In 1997, an updated meta-analysis by Khuder S. A. and Mutgi A. B. [16], incorporating results from 32 studies published between 1981 and 1996, confirmed the positive association between farming and MM (RR: 1.23; 95% CI: 1.14–1.32).

The risk of hematologic malignancies in pesticide-related occupations was evaluated by Merhi M. et al. [28]. In their meta-analysis, among a subset of 13 case–control studies, two of them were restricted to MM risk. They concluded that the use of pesticides in occupational activities may increase MM risk, but this was not statistically significant (pooled OR: 1.16; 95% CI: 0.99–1.36; p = 0.06).

Perrotta C. et al. [17] also confirmed the increased risk in developing MM for farmers (OR: 1.39; 95% CI: 1.18–1.65) and for those working with pesticides (OR: 1.47; 95% CI: 1.11–1.94), in a meta-analysis of 28 case–control studies, with the limitations of significant heterogeneity across the studies and publication bias in some models. Recently, a meta-analysis of one cohort and two case–control studies [18] revealed a lack of association between the exposure to glyphosate, a broad-spectrum systemic herbicide and crop desiccant, and MM risk (meta-RR: 1.04; 95% CI: 0.67–1.41; p = 0.21).

3.2. Firefighting

A meta-analysis of eight mortality studies in 2006 [29] revealed an elevated pooled relative risk for MM among firefighters (Summary Risk Estimate (SRE): 1.53; 95% CI: 1.21–1.94). Similar significant and consistent findings were also identified in the updated meta-analysis by Soteriades E. S. et al. [19]; the relative risk estimate for mortality was 1.28 (95% CI: 1.03–1.58; p < 0.05). Potential causative compounds include benzene, PAHs, aldehydes, and other organic chemicals.

3.3. Hairdressing and Allied Occupations

Takkouche B. et al. [20] found that across 19 studies, hairdresser occupation increases the risk of MM by 62% (the fixed-effects RR: 1.38; 95% CI: 1.25–1.54; the random-effects RR: 1.62; 95% CI: 1.22–2.14; p = 0.0001). Frequently used hazardous chemicals among hairdressers include formaldehyde, ammonium compounds, polyvinylpyrrolidone, and organic solvents.

3.4. Organic Solvents

The meta-analysis of case–control studies conducted by Sonoda T. et al. [21] indicated a statistically significant positive association between MM risk and engine exhaust exposure (OR: 1.34; 95% CI: 1.14–1.57), but failed to identify significant associations for petroleum, petroleum products, and benzene. On the contrary, in a meta-analysis of seven cohort studies, Infante P. F. [30] demonstrated a statistically significant correlation between benzene exposure and risk of death from MM (RR: 2.13; 95% CI: 1.31–3.46). The updated meta-analysis by Vlaanderen J. et al. [22], synthesizing 26 cohort studies, revealed a slight, nonsignificant elevation of the overall meta-RR for those who experience occupational benzene exposure (meta-RR: 1.12; 95% CI: 0.98–1.27). Recently, Onyije F. M. et al. [23], in a meta-analysis consisting of 11 cohort studies and one case–control study, demonstrated consistent positive findings regarding petroleum industry work and incidence of MM (estimated risk of 1.80; 95% CI: 1.28–2.55), yet failed to support significant correlation between petroleum exposure and risk of mortality from MM (estimated risk of 1.04; 95% CI: 0.89–1.21).

The results from a meta-analysis of seven cohort studies [31] did not support associations between occupational TCE exposure and MM risk (pooled RR: 1.05; 95% CI: 0.80–1.38; p-heterogeneity: 0.94). Consistent findings had been revealed by a more recent study of Karami S. et al. [24]; meta-analytical results of nine cohort and two case–control studies failed to report significant associations between TCE exposure and MM (RR: 1.05; 95% CI: 0.88–1.27; p-heterogeneity: 0.76).

Regarding exposure to methylene chloride and MM risk, the meta-analysis of Liu T. et al. [25] included one case–control and two cohort studies and pointed to a positive, significant association (the fixed-effects OR: 2.04; 95% CI: 1.31–3.17) without evidence of heterogeneity among studies. Both mechanistic and epidemiological studies are ultimately warranted to provide insights into the carcinogenic potential of methylene chloride, and the realistic risk of hematopoietic cancer in particular.

3.5. Other Occupational Factors

Alicandro G. et al. [26] conducted a meta-analysis of 11 cohort studies examining the risk of lymphatic and hematopoietic neoplasms among workers exposed to polycyclic aromatic hydrocarbons (PAHs). Meta-analytic estimates revealed a nonsignificant excess risk of MM (meta-RR: 1.18; 95% CI: 0.93–1.50) among workers in aluminum production. On the contrary, no associations were found between MM and occupational exposure for iron and steel foundry workers (meta-RR: 1; 95% CI: 0.67–1.51; p = 0.26) and occupational exposure for asphalt workers (meta-RR: 0.72; 95% CI: 0.42–1.23; p = 0.77). Overall, at the sample size of the included studies, a positive correlation between PAHs exposure and MM risk could not be identified, with the effect size commensurate with the power of the studies.

4. Discussion

To date, results from epidemiological studies of potential risk for MM mediated by occupation exposure have been inconsistent. In particular, several risk factors across five categories, including farming, firefighting, hairdressing, and organic solvents and PAHs exposure have been studied for an underlying causal association with MM. Herein, we provided an overview and appraisal of the occupational epidemiology of MM, presenting data from published meta-epidemiological studies. Since publication of the previous systematic review of meta-analyses by Sergentanis T. N. et al. [14], four new meta-analyses of occupational exposures and MM were considered in our updated review [18,19,23,26]; nonsignificant associations between glyphosate [18], PAHs [26], and petroleum [23] exposure and MM risk have been reported, whereas, consistent with previous findings [29], firefighting correlated with increased risk of death from MM [19]. Overall, the results from the included meta-epidemiological studies [16,17,18,19,20,21,22,23,24,25,26] in this updated review confirm the statistically significant risk for MM among firefighters, hairdressers, and employees exposed to engine exhaust, highlighting the multifactorial traits of the disease.

Findings from studies of farming-related occupations and MM risk have been inconsistent, ranging from positive associations [32,33,34,35,36,37,38,39] to inverse associations [27,40,41,42,43,44,45,46,47,48,49,50]. In a large pooled analysis of five international case–control studies [51] including 1959 MM cases and 6192 control subjects over a period of 30 years, gardeners and nursery workers possibly exposed to pesticides, showed a 50% increase in risk (OR:1.50; 95% CI: 0.9–2.3) while other agricultural jobs did not. With regard to published meta-analyses, as presented in our review, Khuder S. A. et al. [16] and Perrotta C. et al. [17] highlighted farming as a risk factor, whereas Donato F. et al. [18] did not find significant associations between MM and pesticide and herbicide exposure, respectively, which could be attributed to the relatively small sample size, and thus, to inadequate statistical power.

Moreover, we should also address that in agriculture the range of occupational exposure is quite broad, considering that farmers may use a number of hazardous products, including pesticides, herbicides, engine fuels and exhausts, fertilizers, and other chemical solvents [52,53]. As a result, the heterogeneity of both type and dose level of exposure, in addition with the variety in intensity of exposure (i.e., duration of working time or seasonal application of pesticides and herbicides) could partially explain the observed inconsistency across published studies, and thus should not be underestimated.

With regard to firefighting, in a pooled cohort of 30,000 US firefighters, Daniels R. D. et al. [54] reported increased cancer incidence among this occupational group, in comparison with the general population. Soteriades E. S. et al. [19] highlighted the increased risk of MM among firefighters. Indeed, during firefighting activities, firefighters may be exposed (via inhalation and/or dermal absorption) to both known and suspected carcinogens, including acetaldehyde, formaldehyde, the non-threshold toxicant benzene, PAHs, asbestos, cadmium, and arsenic [29,55,56,57,58,59]. Given the varied exposure and emissions levels, the quantification of relative myeloma risk remains quite challenging.

Employees in hairdressing salons, barbershops, and beauty salons are also exposed to a variety of agents released from hairdressing and beauty products, like hydrogen peroxide, ammonia, formaldehyde, nitrosamines, polyvinylpyrrolidone/polyvinyl-acetate copolymer (PVP-PVA), some of which have been suggested as mutagenic or carcinogenic [60]. In a large meta-analysis, with no evidence of publication bias, but with high degree heterogeneity among included studies, Takkouche B. et al. [20] found a significant positive correlation between MM and the hairdresser’s profession. Despite usually being short-term, the repetitive airborne and dermal exposure to certain hazardous chemicals, and especially organic solvents, could explain the elevated MM risk in this occupational cohort.

Benzene, one of the elementary petrochemicals widely used for the production of polymers, plastics, rubbers, dyes, pesticides, lubricants, and as a component of unleaded gasoline, has been associated with hematopoietic cancer, including MM [61]. The first meta-analysis, which included only case–control studies [21], failed to detect any significant correlation between occupational benzene and petroleum exposure with MM, but suggested a significant positive association with engine exhaust exposure. Similarly, a recent meta-analysis comprising one case–control and 11 cohort studies [23] noted increased risk for MM among petroleum industry workers.

Additionally, no supportive evidence for increased MM risk following occupational exposure to TCE [23] and PAHs [25] could be identified, while meta-analytical results yielded positive associations of methylene chloride exposure and MM [25].

Our study has several caveats, which we should critically point out as they reflect key limitations of meta-analyses. Firstly, given the relative rarity of MM, cohort studies may lack adequate statistical power, while case–control studies may suffer from small sample sizes for specific occupational categories [62,63]. Moreover, in case–control studies, selective enrolment of participants as controls could introduce selection bias, whereas differential recall, between cases and controls, of information on exposure depending on their outcome could introduce recall bias [62]. In addition, the presence of confounding factors, the exposure to a variety of chemical agents in agricultural work environments, and limitations of used statistical methods could blur the results of occupational epidemiological studies [64]. Additionally, both studies’ heterogeneity and publication bias represent challenges in the interpretation of meta-analyses [64].

Furthermore, we need to address that overlapping data between specific studies may occur, leading to spurious associations and false positive results. Of note, despite the fact that 14 studies [65,66,67,68,69,70,71,72,73,74,75,76,77,78] included in the meta-analysis by Khuder S. A. et al. [16] were also included in the meta-analysis by Perrotta C. et al. [17] (Table 2), they were both retained because the second comprised of only case–control studies, while the first also contained two cohort studies. Lastly, it is evident from Table 1 that some of the included meta-analyses were of low methodological quality, given the poorly reported essential elements of their study design or results, thus diminishing their value to clinicians and policy makers.

Table 2.

Overlapping studies from the meta-analyses by Khuder S. A. et al. and Perrotta C. et al.

Author (Publication Year) Type of Case–Control Study Total Number of Exposed Cases Relative Risk (95% CI)
Gallagher et al. (1983) [65] Incident 31 2.20 (1.20–4.00)
Cantor and Blair (1984) [66] Mortality 175 1.40 (1.00–1.80)
Nandakumar et al. (1986) [67] Mortality 21 1.44 (0.81–2.55)
Pearce et al. (1986) [68] Incident 43 1.70 (1.00–2.90)
Flodin et al. (1987) [69] Incident 30 1.90 (1.10–3.10)
Cuzick and De Stavola (1988) [70] Incident 28 1.60 (0.87–2.94)
Brownson et al. (1988) [71] Incident 24 1.40 (0.87–2.24)
Boffetta et al. (1989) [72] Incident 16 3.40 (1.50–7.50)
La Vecchia et al. (1989) [73] Incident 25 1.90 (1.10–3.20)
Heineman et al. (1992) [74] Incident 45 1.10 (0.80–1.50)
Eriksson and Karlsson (1992) [75] Incident 151 1.68 (1.16–2.44)
Blair et al. (1993) [76] Mortality 489 1.13 (1.03–1.24)
Demers et al. (1993) [77] Incident 26 1.20 (0.80–2.50)
Francheschi et al. (1993) [78] Mortality 20 1.30 (0.70–2.30)

Abbreviations: CI = confidence interval.

Moreover, the identification of specific occupational categories related with an increased risk of MM enables public health officials to not only identify populations (i.e., with plasma cell precursor conditions like MGUS and SMM) in need of earlier and more frequent screening tests (i.e., serum and urine protein electrophoresis), but also implement feasible and effective preventive measures. Thus, large-scale epidemiological studies of high quality are warranted to investigate and further characterize potential workplace hazards related with MM.

5. Conclusions

In summary, the present review focused on the published meta-analyses that summarize current knowledge on occupational risk factors for MM epidemiology. Additional evidence from well-designed epidemiological studies in the near future is anticipated to further shed light on repeatedly reported associations of MM risk with various occupational risk factors.

Author Contributions

Conceptualization, M.A.D. and F.Z.; data curation, R.G. and O.F.; formal analysis, R.G., O.F., T.N.S. and A.A.; supervision, F.Z., M.G., T.P., E.K., E.T. and M.A.D.; writing—original draft, R.G. and O.F.; writing—review and editing, R.G., O.F., T.N.S., A.A., F.Z., M.G., T.P., E.K., E.T. and M.A.D. All authors agreed with the content, all gave explicit consent to submit, and all obtained consent from the responsible authorities at the institute where the study was carried out. E.T. is the corresponding author and guarantor of the review. All authors have read and agreed to the published version of the manuscript.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflicts of Interest

M.A.D. has received honoraria from participation in advisory boards from Amgen, Bristol-Myers-Squibb, Celgene, Janssen, and Takeda. F.Z. has received honoraria for lectures and has served in an advisory role for Astra-Zeneca, Daiichi, Eli-Lilly, Merck, Novartis, Pfizer, and Roche. E.T. has received grants, personal fees, and non-financial support from Janssen, Celgene, Takeda, Amgen, Genesis Pharma, and BMS. E.K. has received honoraria/personal fees from Amgen, Genesis Pharma, Janssen, Takeda, and Prothena and research grants from Amgen and Janssen. The remaining authors declare no conflict of interest.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Cartwright R.A., Alexander F.E., McKinney P.A. Leukemia and Lymphoma: An. Atlas of Distribution Within Areas of England and Wales 1984–1988. Leukemia Research Fund; London, UK: 1990. [Google Scholar]
  • 2.McNally R.J., Roman E., Cartwright R.A. Leukemias and lymphomas: Time trends in the UK, 1984–1993. Cancer Causes Control. 1999;10:35–42. doi: 10.1023/A:1008859730818. [DOI] [PubMed] [Google Scholar]
  • 3.Swerdlow S.H., Campo E., Harris N.L., Jaffe E.S., Pileri S.A., Stein H., Thiele J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. WHO Press; Geneva, Switzerland: 2008. [Google Scholar]
  • 4.Moreau P., San Miguel J., Sonneveld P., Mateos M.V., Zamagni E., Avet-Loiseau H., Hajek R., Dimopoulos M.A., Ludwig H., Einsele H., et al. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017;28((Suppl. 4)):iv52–iv61. doi: 10.1093/annonc/mdx096. [DOI] [PubMed] [Google Scholar]
  • 5.Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394–424. doi: 10.3322/caac.21492. [DOI] [PubMed] [Google Scholar]
  • 6.Kumar S.K., Dispenzieri A., Lacy M.Q., Gertz M.A., Buadi F.K., Pandey S., Kapoor P., Dingli D., Hayman S.R., Leung N., et al. Continued improvement in survival in multiple myeloma: Changes in early mortality and outcomes in older patients. Leukemia. 2014;28:1122–1128. doi: 10.1038/leu.2013.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Howlader N., Noone A.M., Krapcho M., Miller D., Brest A., Yu M., Ruhl J., Tatalovich Z., Mariotto A., Lewis D.R., et al. SEER Cancer Statistics Review, 1975–2016, National Cancer Institute, Bethesda, MD, Based on November 2018 SEER Data Submission, Posted to the SEER Website, April 2019. [(accessed on 20 August 2021)]; Available online: https://seer.cancer.gov/csr/1975_2016/
  • 8.García-Ortiz A., Rodríguez-García Y., Encinas J., Maroto-Martín E., Castellano E., Teixidó J., Martínez-López J. The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression. Cancers. 2021;13:217. doi: 10.3390/cancers13020217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Landgren O., Kyle R.A., Pfeiffer R.M., Katzmann J.A., Caporaso N.E., Hayes R.B., Dispenzieri A., Kumar S., Clark R.J., Baris D., et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: A prospective study. Blood. 2009;113:5412–5417. doi: 10.1182/blood-2008-12-194241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ries L.A.G., Eisner M.P., Kosary C.L., Hankey B.F., Miller B.A., Clegg L., Mariotto A., Feuer E.J., Edwards B.K., editors. SEER Cancer Statistics Review, 1975–2002. National Cancer Institute; Bethesda, MD, USA: 2002. [(accessed on 20 August 2021)]. Available online: https://seer.cancer.gov/csr/1975_2002/ [Google Scholar]
  • 11.Bowden M., Crawford J., Cohen H.J., Noyama O. A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly. J. Am. Geriatr. Soc. 1993;41:11–14. doi: 10.1111/j.1532-5415.1993.tb05940.x. [DOI] [PubMed] [Google Scholar]
  • 12.Alexander D.D., Mink P.J., Adami H.O., Cole P., Mandel J.S., Oken M.M., Trichopoulos D. Multiple myeloma: A review of the epidemiologic literature. Int. J. Cancer. 2007;120((Suppl. 12)):40–61. doi: 10.1002/ijc.22718. [DOI] [PubMed] [Google Scholar]
  • 13.Kyle R.A., Rajkumar S.V. Epidemiology of the plasma-cell disorders. Best Pract. Res. Clin. Haematol. 2007;20:637–664. doi: 10.1016/j.beha.2007.08.001. [DOI] [PubMed] [Google Scholar]
  • 14.Sergentanis T.N., Zagouri F., Tsilimidos G., Tsagianni A., Tseliou M., Dimopoulos M.A., Psaltopoulou T. Risk Factors for Multiple Myeloma: A Systematic Review of Meta-Analyses. Clin. Lymphoma Myeloma Leuk. 2015;15:563–577.e773. doi: 10.1016/j.clml.2015.06.003. [DOI] [PubMed] [Google Scholar]
  • 15.McElvenny D.M., Armstrong B.G., Järup L., Higgins J.P. Meta-analysis in occupational epidemiology: A review of practice. Occup. Med. 2004;54:336–344. doi: 10.1093/occmed/kqh049. [DOI] [PubMed] [Google Scholar]
  • 16.Khuder S.A., Mutgi A.B. Meta-analyses of multiple myeloma and farming. Am. J. Ind. Med. 1997;32:510–516. doi: 10.1002/(SICI)1097-0274(199711)32:5&#x0003c;510::AID-AJIM11&#x0003e;3.0.CO;2-5. [DOI] [PubMed] [Google Scholar]
  • 17.Perrotta C., Staines A., Cocco P. Multiple myeloma and farming. A systematic review of 30 years of research. Where next? J. Occup. Med. Toxicol. 2008;3:27. doi: 10.1186/1745-6673-3-27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Donato F., Pira E., Ciocan C., Boffetta P. Exposure to glyphosate and risk of non-Hodgkin lymphoma and multiple myeloma: An updated meta-analysis. Med. Lav. 2020;111:63–73. doi: 10.23749/mdl.v111i1.8967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Soteriades E.S., Kim J., Christophi C.A., Kales S.N. Cancer Incidence and Mortality in Firefighters: A State-of-the-Art Review and Meta-Analysis. Asian Pac. J. Cancer Prev. 2019;20:3221–3231. doi: 10.31557/APJCP.2019.20.11.3221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Takkouche B., Regueira-Méndez C., Montes-Martínez A. Risk of cancer among hairdressers and related workers: A meta-analysis. Int. J. Epidemiol. 2009;38:1512–1531. doi: 10.1093/ije/dyp283. [DOI] [PubMed] [Google Scholar]
  • 21.Sonoda T., Nagata Y., Mori M., Ishida T., Imai K. Meta-analysis of multiple myeloma and benzene exposure. J. Epidemiol. 2001;11:249–254. doi: 10.2188/jea.11.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Vlaanderen J., Lan Q., Kromhout H., Rothman N., Vermeulen R. Occupational benzene exposure and the risk of lymphoma subtypes: A meta-analysis of cohort studies incorporating three study quality dimensions. Environ. Health Perspect. 2011;119:159–167. doi: 10.1289/ehp.1002318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Onyije F.M., Hosseini B., Togawa K., Schüz J., Olsson A. Cancer Incidence and Mortality among Petroleum Industry Workers and Residents Living in Oil Producing Communities: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2021;18:4343. doi: 10.3390/ijerph18084343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Karami S., Bassig B., Stewart P.A., Lee K.M., Rothman N., Moore L.E., Lan Q. Occupational trichloroethylene exposure and risk of lymphatic and haematopoietic cancers: A meta-analysis. Occup. Environ. Med. 2013;70:591–599. doi: 10.1136/oemed-2012-101212. [DOI] [PubMed] [Google Scholar]
  • 25.Liu T., Xu Q.E., Zhang C.H., Zhang P. Occupational exposure to methylene chloride and risk of cancer: A meta-analysis. Cancer Causes Control. 2013;24:2037–2049. doi: 10.1007/s10552-013-0283-0. [DOI] [PubMed] [Google Scholar]
  • 26.Alicandro G., Rota M., Boffetta P., La Vecchia C. Occupational exposure to polycyclic aromatic hydrocarbons and lymphatic and hematopoietic neoplasms: A systematic review and meta-analysis of cohort studies. Arch. Toxicol. 2016;90:2643–2656. doi: 10.1007/s00204-016-1822-8. [DOI] [PubMed] [Google Scholar]
  • 27.Blair A., Zahm S.H., Pearce N.E., Heineman E.F., Fraumeni J.F., Jr. Clues to cancer etiology from studies of farmers. Scand. J. Work Environ. Health. 1992;18:209–215. doi: 10.5271/sjweh.1578. [DOI] [PubMed] [Google Scholar]
  • 28.Merhi M., Raynal H., Cahuzac E., Vinson F., Cravedi J.P., Gamet-Payrastre L. Occupational exposure to pesticides and risk of hematopoietic cancers: Meta-analysis of case-control studies. Cancer Causes Control. 2007;18:1209–1226. doi: 10.1007/s10552-007-9061-1. [DOI] [PubMed] [Google Scholar]
  • 29.LeMasters G.K., Genaidy A.M., Succop P., Deddens J., Sobeih T., Barriera-Viruet H., Dunning K., Lockey J. Cancer risk among firefighters: A review and meta-analysis of 32 studies. J. Occup. Environ. Med. 2006;48:1189–1202. doi: 10.1097/01.jom.0000246229.68697.90. [DOI] [PubMed] [Google Scholar]
  • 30.Infante P.F. Benzene exposure and multiple myeloma: A detailed meta-analysis of benzene cohort studies. Ann. N. Y. Acad. Sci. 2006;1076:90–109. doi: 10.1196/annals.1371.081. [DOI] [PubMed] [Google Scholar]
  • 31.Alexander D.D., Mink P.J., Mandel J.H., Kelsh M.A. A meta-analysis of occupational trichloroethylene exposure and multiple myeloma or leukaemia. Occup. Med. 2006;56:485–493. doi: 10.1093/occmed/kql083. [DOI] [PubMed] [Google Scholar]
  • 32.Brown L.M., Burmeister L.F., Everett G.D., Blair A. Pesticide exposures and multiple myeloma in Iowa men. Cancer Causes Control. 1993;4:153–156. doi: 10.1007/BF00053156. [DOI] [PubMed] [Google Scholar]
  • 33.Ronco G., Costa G., Lynge E. Cancer risk among Danish and Italian farmers. Br. J. Ind. Med. 1992;49:220–225. doi: 10.1136/oem.49.4.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Semenciw R.M., Morrison H.I., Riedel D., Wilkins K., Ritter L., Mao Y. Multiple myeloma mortality and agricultural practices in the Prairie provinces of Canada. J. Occup. Med. 1993;35:557–561. doi: 10.1097/00043764-199306000-00010. [DOI] [PubMed] [Google Scholar]
  • 35.Baris D., Silverman D.T., Brown L.M., Swanson G.M., Hayes R.B., Schwartz A.G., Liff J.M., Schoenberg J.B., Pottern L.M., Greenberg R.S., et al. Occupation, pesticide exposure and risk of multiple myeloma. Scand. J. Work Environ. Health. 2004;30:215–222. doi: 10.5271/sjweh.782. [DOI] [PubMed] [Google Scholar]
  • 36.Pahwa P., McDuffie H.H., Dosman J.A., Robson D., McLaughlin J.R., Spinelli J.J., Fincham S. Exposure to animals and selected risk factors among Canadian farm residents with Hodgkin’s disease, multiple myeloma, or soft tissue sarcoma. J. Occup. Environ. Med. 2003;45:857–868. doi: 10.1097/01.jom.0000083033.56116.c1. [DOI] [PubMed] [Google Scholar]
  • 37.Figà-Talamanca I., Mearelli I., Valente P., Bascherini S. Cancer mortality in a cohort of rural licensed pesticide users in the province of Rome. Int. J. Epidemiol. 1993;22:579–583. doi: 10.1093/ije/22.4.579. [DOI] [PubMed] [Google Scholar]
  • 38.Alavanja M.C., Blair A., Merkle S., Teske J., Eaton B. Mortality among agricultural extension agents. Am. J. Ind. Med. 1988;14:167–176. doi: 10.1002/ajim.4700140207. [DOI] [PubMed] [Google Scholar]
  • 39.Kristensen P., Andersen A., Irgens L.M., Laake P., Bye A.S. Incidence and risk factors of cancer among men and women in Norwegian agriculture. Scand. J. Work Environ. Health. 1996;22:14–26. doi: 10.5271/sjweh.104. [DOI] [PubMed] [Google Scholar]
  • 40.Schreinemachers D.M. Cancer mortality in four northern wheat-producing states. Environ. Health Perspect. 2000;108:873–881. doi: 10.1289/ehp.00108873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Acquavella J., Olsen G., Cole P., Ireland B., Kaneene J., Schuman S., Holden L. Cancer among farmers: A meta-analysis. Ann. Epidemiol. 1998;8:64–74. doi: 10.1016/S1047-2797(97)00120-8. [DOI] [PubMed] [Google Scholar]
  • 42.Wiklund K., Dich J. Cancer risks among male farmers in Sweden. Eur. J. Cancer Prev. 1995;4:81–90. doi: 10.1097/00008469-199502000-00008. [DOI] [PubMed] [Google Scholar]
  • 43.Reif J., Pearce N., Fraser J. Cancer risks in New Zealand farmers. Int. J. Epidemiol. 1989;18:768–774. doi: 10.1093/ije/18.4.768. [DOI] [PubMed] [Google Scholar]
  • 44.Wiklund K., Dich J. Cancer risks among female farmers in Sweden. Cancer Causes Control. 1994;5:449–457. doi: 10.1007/BF01694759. [DOI] [PubMed] [Google Scholar]
  • 45.Pukkala E., Notkola V. Cancer incidence among Finnish farmers, 1979–1993. Cancer Causes Control. 1997;8:25–33. doi: 10.1023/A:1018474919807. [DOI] [PubMed] [Google Scholar]
  • 46.Lee W.J., Hoppin J.A., Blair A., Lubin J.H., Dosemeci M., Sandler D.P., Alavanja M.C. Cancer incidence among pesticide applicators exposed to alachlor in the Agricultural Health Study. Am. J. Epidemiol. 2004;159:373–380. doi: 10.1093/aje/kwh040. [DOI] [PubMed] [Google Scholar]
  • 47.Gambini G.F., Mantovani C., Pira E., Piolatto P.G., Negri E. Cancer mortality among rice growers in Novara Province, northern Italy. Am. J. Ind. Med. 1997;31:435–441. doi: 10.1002/(SICI)1097-0274(199704)31:4&#x0003c;435::AID-AJIM9&#x0003e;3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  • 48.Torchio P., Lepore A.R., Corrao G., Comba P., Settimi L., Belli S., Magnani C., di Orio F. Mortality study on a cohort of Italian licensed pesticide users. Sci. Total Environ. 1994;149:183–191. doi: 10.1016/0048-9697(94)90178-3. [DOI] [PubMed] [Google Scholar]
  • 49.Viel J.F., Richardson S.T. Lymphoma, multiple myeloma and leukaemia among French farmers in relation to pesticide exposure. Soc. Sci. Med. 1993;37:771–777. doi: 10.1016/0277-9536(93)90371-A. [DOI] [PubMed] [Google Scholar]
  • 50.Zhong Y., Rafnsson V. Cancer incidence among Icelandic pesticide users. Int. J. Epidemiol. 1996;25:1117–1124. doi: 10.1093/ije/25.6.1117. [DOI] [PubMed] [Google Scholar]
  • 51.Perrotta C., Kleefeld S., Staines A., Tewari P., De Roos A.J., Baris D., Birmann B., Chiu B., Cozen W., Becker N., et al. Multiple myeloma and occupation: A pooled analysis by the International Multiple Myeloma Consortium. Cancer Epidemiol. 2013;37:300–305. doi: 10.1016/j.canep.2013.01.008. [DOI] [PubMed] [Google Scholar]
  • 52.Blair A., Freeman L.B. Epidemiologic studies in agricultural populations: Observations and future directions. J. Agromed. 2009;14:125–131. doi: 10.1080/10599240902779436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Blair A. Cancer risks associated with agriculture: Epidemiologic evidence. Basic Life Sci. 1982;21:93–111. doi: 10.1007/978-1-4684-4352-3_9. [DOI] [PubMed] [Google Scholar]
  • 54.Daniels R.D., Kubale T.L., Yiin J.H., Dahm M.M., Hales T.R., Baris D., Zahm S.H., Beaumont J.J., Waters K.M., Pinkerton L.E. Mortality and cancer incidence in a pooled cohort of US firefighters from San Francisco, Chicago and Philadelphia (1950–2009) Occup. Environ. Med. 2014;71:388–397. doi: 10.1136/oemed-2013-101662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Brandt-Rauf P.W., Fallon L.F., Jr., Tarantini T., Idema C., Andrews L. Health hazards of fire fighters: Exposure assessment. Br. J. Ind. Med. 1988;45:606–612. doi: 10.1136/oem.45.9.606. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Fabian T.Z., Borgerson J.L., Gandhi P.D., Baxter C.S., Ross C.S., Lockey J.E., Dalton J.M. Characterization of firefighter smoke exposure. Fire Technol. 2014;50:993–1019. doi: 10.1007/s10694-011-0212-2. [DOI] [Google Scholar]
  • 57.Bolstad-Johnson D.M., Burgess J.L., Crutchfield C.D., Storment S., Gerkin R., Wilson J.R. Characterization of firefighter exposures during fire overhaul. Am. Ind. Hyg. Assoc. J. 2000;61:636–641. doi: 10.1202/0002-8894(2000)061&#x0003c;0636:COFEDF&#x0003e;2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 58.Baxter C.S., Hoffman J.D., Knipp M.J., Reponen T., Haynes E.N. Exposure of Firefighters to Particulates and Polycyclic Aromatic Hydrocarbons. J. Occup. Environ. Hyg. 2014;11:D85–D91. doi: 10.1080/15459624.2014.890286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Oliveira M., Slezakova K., Alves M.J., Fernandes A., Teixeira J.P., Delerue-Matos C., Pereira M.D.C., Morais S. Polycyclic aromatic hydrocarbons at fire stations: Firefighters’ exposure monitoring and biomonitoring, and assessment of the contribution to total internal dose. J. Hazard. Mater. 2017;323:184–194. doi: 10.1016/j.jhazmat.2016.03.012. [DOI] [PubMed] [Google Scholar]
  • 60.Ames B.N., Kammen H.O., Yamasaki E. Hair dyes are mutagenic: Identification of a variety of mutagenic ingredients. Proc. Natl. Acad. Sci. USA. 1975;72:2423–2427. doi: 10.1073/pnas.72.6.2423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Chemical Agents and Related Occupations (IARC) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100. IARC; Lyon, France: 2012. pp. 249–294. [PMC free article] [PubMed] [Google Scholar]
  • 62.Tenny S., Kerndt C.C., Hoffman M.R. Case Control Studies. StatPearls Publishing; Treasure Island, FL, USA: 2020. [PubMed] [Google Scholar]
  • 63.Munnangi S., Boktor S.W. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2020. Epidemiology of Study Design. [PubMed] [Google Scholar]
  • 64.Crowther M., Lim W., Crowther M.A. Systematic review and meta-analysis methodology. Blood. 2010;116:3140–3146. doi: 10.1182/blood-2010-05-280883. [DOI] [PubMed] [Google Scholar]
  • 65.Gallagher R.P., Spinelli J.J., Elwood J.M., Skippen D.H. Allergies and agricultural exposure as risk factors for multiple myeloma. Br. J. Cancer. 1983;48:853–857. doi: 10.1038/bjc.1983.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Cantor K.P., Blair A. Farming and mortality from multiple myeloma: A case-control study with the use of death certificates. J. Natl. Cancer Inst. 1984;72:251–255. [PubMed] [Google Scholar]
  • 67.Nandakumar A., Armstrong B.K., de Klerk N.H. Multiple myeloma in Western Australia: A case-control study in relation to occupation, father’s occupation, socioeconomic status and country of birth. Int. J. Cancer. 1986;37:223–226. doi: 10.1002/ijc.2910370209. [DOI] [PubMed] [Google Scholar]
  • 68.Pearce N.E., Smith A.H., Howard J.K., Sheppard R.A., Giles H.J., Teague C.A. Case-control study of multiple myeloma and farming. Br. J. Cancer. 1986;54:493–500. doi: 10.1038/bjc.1986.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Flodin U., Fredriksson M., Persson B. Multiple myeloma and engine exhausts, fresh wood, and creosote: A case-referent study. Am. J. Ind. Med. 1987;12:519–529. doi: 10.1002/ajim.4700120506. [DOI] [PubMed] [Google Scholar]
  • 70.Cuzick J., De Stavola B. Multiple myeloma—A case-control study. Br. J. Cancer. 1988;57:516–520. doi: 10.1038/bjc.1988.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Brownson R.C., Reif J.S. A cancer registry-based study of occupational risk for lymphoma, multiple myeloma and leukaemia. Int. J. Epidemiol. 1988;17:27–32. doi: 10.1093/ije/17.1.27. [DOI] [PubMed] [Google Scholar]
  • 72.Boffetta P., Stellman S.D., Garfinkel L. A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int. J. Cancer. 1989;43:554–559. doi: 10.1002/ijc.2910430404. [DOI] [PubMed] [Google Scholar]
  • 73.La Vecchia C., Negri E., D’Avanzo B., Franceschi S. Occupation and lymphoid neoplasms. Br. J. Cancer. 1989;60:385–388. doi: 10.1038/bjc.1989.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Heineman E.F., Olsen J.H., Pottern L.M., Gomez M., Raffn E., Blair A. Occupational risk factors for multiple myeloma among Danish men. Cancer Causes Control. 1992;3:555–568. doi: 10.1007/BF00052753. [DOI] [PubMed] [Google Scholar]
  • 75.Eriksson M., Karlsson M. Occupational and other environmental factors and multiple myeloma: A population based case-control study. Br. J. Ind. Med. 1992;49:95–103. doi: 10.1136/oem.49.2.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Blair A., Dosemeci M., Heineman E.F. Cancer and other causes of death among male and female farmers from twenty-three states. Am. J. Ind. Med. 1993;23:729–742. doi: 10.1002/ajim.4700230507. [DOI] [PubMed] [Google Scholar]
  • 77.Demers P.A., Vaughan T.L., Koepsell T.D., Lyon J.L., Swanson G.M., Greenberg R.S., Weiss N.S. A case-control study of multiple myeloma and occupation. Am. J. Ind. Med. 1993;23:629–639. doi: 10.1002/ajim.4700230410. [DOI] [PubMed] [Google Scholar]
  • 78.Franceschi S., Barbone F., Bidoli E., Guarneri S., Serraino D., Talamini R., La Vecchia C. Cancer risk in farmers: Results from a multi-site case-control study in north-eastern Italy. Int. J. Cancer. 1993;53:740–745. doi: 10.1002/ijc.2910530506. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Medicine are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES